Protective efficacy of group A streptococcal vaccines containing type-specific and conserved M protein epitopes.
about
Accelerating the development of a group A Streptococcus vaccine: an urgent public health needCorrelates of Protection for M Protein-Based Vaccines against Group A StreptococcusRegion specific and worldwide distribution of collagen-binding M proteins with PARF motifs among human pathogenic streptococcal isolates.A novel live vector group A streptococcal emm type 9 vaccine delivered intranasally protects mice against challenge infection with emm type 9 group A streptococci.Staphylococcal and streptococcal superantigen exotoxinsProtective immunogenicity of group A streptococcal M-related proteins.Strategic development of the conserved region of the M protein and other candidates as vaccines to prevent infection with group A streptococci.Prospective Longitudinal Analysis of Immune Responses in Pediatric Subjects After Pharyngeal Acquisition of Group A Streptococci.Potential coverage of a multivalent M protein-based group A streptococcal vaccine.Group A Streptococcal vaccine candidate: contribution of epitope to size, antigen presenting cell interaction and immunogenicity.Variation, Indispensability, and Masking in the M protein.Structure-based design of broadly protective group a streptococcal M protein-based vaccines.Linear and branched polyacrylates as a delivery platform for peptide-based vaccines.
P2860
Q26739210-33776477-4F1F-449B-BC45-8BFC4F4130FEQ27009175-D92CB77A-E160-4437-A8F4-68C4A2E88249Q34131103-3BF4358A-042E-423E-AB0D-561ED56BD890Q34260712-B71165E3-826D-4891-B884-DD3000BE517AQ34355243-D175F4A5-8570-4D34-9407-F1C947DF6129Q35122760-465264A1-541C-4807-8F4E-668D6F41EC27Q38612165-6523023F-7089-4787-A72E-B614D95468DEQ40068749-C321C38C-1D60-48AE-A15C-CFE2BD7868FEQ40258664-06CC7243-E4B5-4350-A51A-661D4B7EB2C9Q41588446-4199F1B6-D273-4F82-AEC8-F24B0300C421Q46118537-E36C5E70-144D-4483-BEA1-5B373A5508ACQ47100337-3BF02D6A-5243-4F65-BD40-608A22676CBBQ51539386-4D377ED3-9B2A-45E4-8D48-4FC354AA41F9
P2860
Protective efficacy of group A streptococcal vaccines containing type-specific and conserved M protein epitopes.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Protective efficacy of group A ...... conserved M protein epitopes.
@ast
Protective efficacy of group A ...... conserved M protein epitopes.
@en
Protective efficacy of group A ...... conserved M protein epitopes.
@nl
type
label
Protective efficacy of group A ...... conserved M protein epitopes.
@ast
Protective efficacy of group A ...... conserved M protein epitopes.
@en
Protective efficacy of group A ...... conserved M protein epitopes.
@nl
prefLabel
Protective efficacy of group A ...... conserved M protein epitopes.
@ast
Protective efficacy of group A ...... conserved M protein epitopes.
@en
Protective efficacy of group A ...... conserved M protein epitopes.
@nl
P2093
P2860
P1433
P1476
Protective efficacy of group A ...... d conserved M protein epitopes
@en
P2093
Edna Y Chiang
Elwaleed A Ahmed
Thomas A Penfound
P2860
P304
P356
10.1016/J.VACCINE.2010.05.018
P407
P50
P577
2010-05-21T00:00:00Z